NCT04547725View on ClinicalTrials.gov

Complete Cytoreduction Followed by IP and Systemic Chemotherapies for Gastric Cancer With Peritoneal Carcinomatosis

NARecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 16, 2020

Primary Completion Date

March 16, 2026

Study Completion Date

September 16, 2028

Conditions
Gastric CancerPeritoneal Carcinomatosis
Interventions
OTHER

CRS followed by IP and systemic chemotherapies

Complete cytoreductive surgery (CRS) + normothermic intraperitoneal chemotherapy (N-IPEC) + systemic chemotherapy

Trial Locations (1)

100

RECRUITING

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER